ARTIFICIAL INTELLIGENCE FOR BONE MARROW IMAGE–BASED DIAGNOSIS OF MYELODYSPLASTIC NEOPLASMS: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Ahmed Elgebaly, 4211113

STABILITY OF COMPLETE BLOOD COUNT PARAMETERS STORED AT 4°C

EHA Library, Ikbel Ghachem, 4211111

DIAGNOSTIC VALUE OF BONE MARROW BIOPSY IN POST-TRANSPLANTATION RELAPSE OF PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Miao He, 4211117

MISCLUS: MISASSEMBLY CLUSTERING BASED ON PAIRED-END READS

EHA Library, Junqing Xu, 4211115

NEW MULTIPARAMETRIC FLOW CYTOMETRY DATA ANALYSIS USING A COMBINED FLOWSOM AND BAYESIAN PROCESS. APPLICATION TO PERIPHERAL BLOOD LEUKOCYTE DIFFERENTIAL.BACKGROUND.

EHA Library, Marie Christine Béné, 4211114

OPTIMIZING SUBCUTANEOUS SYSTEMIC ANTICANCER THERAPY (SACT) DELIVERY: UNITED KINGDOM NURSE AND PHARMACIST PERSPECTIVES ON ON-BODY INJECTORS VERSUS MANUAL SYRINGES FOR LARGE-VOLUME ADMINISTRATION

EHA Library, Haydon DuMond, 4211116

A COMPARATIVE STUDY OF GENERATIVE AI IN HEALTH EDUCATION SUPPORT FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS: CHATGPT-4O VS. DEEPSEEK-V3

EHA Library, Shashali Shasha, 4211112

Test

EHA Library, Faculty / Presenters, 4177687

IBRUTINIB PLUS VENETOCLAX WITH MRD-GUIDED DURATION OF TREATMENT IS SUPERIOR TO BOTH CONTINUOUS IBRUTINIB MONOTHERAPY AND FCR FOR PREVIOUSLY UNTREATED CLL: REPORT OF THE PHASE III UK FLAIR STUDY

EHA Library, Talha Munir, 4159232

FINAL ANALYSIS OF FIXED-DURATION IBRUTINIB + VENETOCLAX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL) IN THE PHASE 2 CAPTIVATE STUDY

EHA Library, Paolo Ghia, 4159233

UPDATED EFFICACY AND SAFETY OF THE BRUTON TYROSINE KINASE (BTK) DEGRADER BGB-16673 IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) CLL/SLL: RESULTS FROM THE ONGOING PHASE (PH) 1 CADANCE-101 STUDY

EHA Library, Lydia Scarfò, 4159235

UPDATED RESULTS FROM THE PHASE 1 STUDY OF SONROTOCLAX (BGB-11417), A NOVEL BCL2 INHIBITOR, IN COMBINATION WITH ZANUBRUTINIB FOR RELAPSED/REFRACTORY CLL/SLL DEMONSTRATE DEEP AND DURABLE RESPONSES

EHA Library, Chan Y. Cheah, 4159236

EFFICACY AND SAFETY OF AZACITIDINE IN VEXAS SYNDROME:LARGE SCALE STUDY FROM THE FRENVEX

EHA Library, Thibault Comont, 4159252

A DECISION SUPPORT SYSTEM FOR PERSONALIZED OPTIMIZATION OF HEMATOPOIETIC STEM CELL TRANSPLANTATION TIMING IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Matteo Giovanni Della Porta, 4159253

MINIMAL RESIDUAL DISEASE-DRIVEN STRATEGY FOLLOWING ISATUXIMAB-CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE INDUCTION IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: PRIMARY ENDPOINTS OF THE PHASE 3 MIDAS TRIAL

EHA Library, Aurore Perrot, 4159282

A RANDOMIZED, MULTI-CENTER STUDY OF CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE (KRD) WITH OR WITHOUT DARATUMUMAB (D) FOR THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): THE ADVANCE CLINICAL TRIAL

EHA Library, C. Ola Landgren, 4159284

INCA035784, A NOVEL, EQUIPOTENT T CELL-REDIRECTING ANTIBODY FOR PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS CARRYING DIFFERENT TYPES OF CALRETICULIN MUTATIONS

EHA Library, Beth Psaila, 4159289

SPATIAL TRANSCRIPTOMIC ANALYSIS IDENTIFIES NOVEL MICROENVIRONMENTAL IMMUNE SIGNATURES AND STROMAL REMODELLING ASSOCIATED WITH FIBROSIS IN MYELOPROLIFERATIVE NEOPLASIA

EHA Library, Rosalin Cooper, 4159291

FRONTLINE PHASE II RITUXIMAB-POLATUZUMAB-GLOFITMAB (R-POLA-GLO) TRIAL DEMONSTRATES A MANAGEABLE SAFETY PROFILE AND HIGH RESPONSE RATES IN ELDERLY AND MEDICAL UNFIT PATIENTS WITH AGGRESSIVE LYMPHOMA

EHA Library, Thomas Melchardt, 4159325

EXCELLENT OUTCOME WITH INTERIM PET ADAPTED TREATMENT REDUCTION IN ELDERLY DLBCL PTS WITH FAVOURABLE PROGNOSIS: RESULTS OF 288 PTS TREATED IN OPTIMAL>60 TRIAL OF THE DSHNHL/GLA

EHA Library, Viola Pöschel, 4159326

LOW RATES OF HIGH-GRADE TOXICITIES WITH GLPG5101, A FRESH, STEM-LIKE, EARLY MEMORY PHENOTYPE ANTI-CD19 CAR T-CELL THERAPY IN PATIENTS WITH NON-HODGKIN LYMPHOMA IN THE ATALANTA-1 STUDY

EHA Library, Pim Mutsaers, 4159358

CTD402: A UNIVERSAL ANTI-CD7 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR PATIENTS WITH RELAPSED OR REFRACTORY (R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL)

EHA Library, Jiangtao Ren, 4159360

PREDICTORS AND OUTCOMES FOR IMMUNE EFFECTOR CELL ASSOCIATED DELAYED NEUROTOXICITIES IN MULTIPLE MYELOMA PATIENTS RECEIVING CILTA-CEL: A REAL WORLD ANALYSIS FROM THREE US CENTERS

EHA Library, Kenneth Jin Chang Lim, 4159361

EFFICACY AND SAFETY OF BRL-101 IN TDT AND SCD

EHA Library, Tan Qian, 4159367

FIRST-IN-HUMAN STUDY OF AUTOLOGOUS HBA2-EDITED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS IN ALPHA-THALASSEMIA WITH CONSTANT SPRING MUTATION

EHA Library, Hui Xu, 4159369

INTRACELLULAR IRON OVERLOAD AND DEFECTIVE STROMAL NICHE IMPAIR HEMATOPOIETIC STEM CELLS IN SICKLE CELL DISEASE

EHA Library, Silvia Sighinolfi, 4159371

PHASE 3 LUNA3 STUDY: FIRST EFFICACY/SAFETY REPORT OF LONG-TERM EXTENSION PERIOD WITH RILZABRUTINIB IN ADULTS WITH PERSISTENT/CHRONIC IMMUNE THROMBOCYTOPENIA

EHA Library, Waleed Ghanima, 4159387

SHORT-TERM RESPONSE AND SAFETY OF DARATUMUMAB TREATMENT IN ADULT IMMUNE THROMBOCYTOPENIA: RESULTS OF A PHASE II STUDY WITH SAFETY RUN-IN (THE DART STUDY)

EHA Library, Galina Tsykunova, 4159388

HLA PROFILE IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: COMPARISON WITH HEALTHY INDIVIDUALS AND PROGNOSTIC IMPLICATIONS

EHA Library, Yessenia Lizbeth Molina Cabrera, 4159391

CLINICAL VALIDATION STUDY OF AN AI SYSTEM FOR BONE MARROW CELL CLASSIFICATION AND DYSPLASIA DETECTION

EHA Library, David Bermejo-Peláez, 4159410

REFINEMENT AND INTERNATIONAL VALIDATION OF A MACHINE LEARNING ALGORITHM FOR CLASSIFYING ACUTE LEUKEMIA SUBTYPES USING ROUTINE LABORATORY DATA

EHA Library, Merlin Engelke, 4159411

ADDITION OF BLINATUMOMAB TO CONSOLIDATION THERAPY FOR YOUNGER ADULTS (BCR:ABL1-NEGATIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) ON THE ECOG-ACRIN E1910 PHASE III TRIAL

EHA Library, Shira Dinner, 4159187

SAFETY AND EFFICACY OF SINGLE-AGENT SUBCUTANEOUS BLINATUMOMAB IN ADULTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): RESULTS FROM A PHASE 1/2 DOSE EXPANSION STUDY

EHA Library, Elias Jabbour, 4159189

STEM CELL AGING CLOCK: A DEEP LEARNING DRIVEN FRAMEWORK FOR PREDICTING STEM CELL AGE

EHA Library, Guanlin Wang, 4159409

A FINE-TUNED FOUNDATION MODEL FOR DIGITAL PATHOLOGY IN MYELODYSPLASTIC SYNDROMES: ADVANCING PERSONALIZED MEDICINE

EHA Library, Gianluca Asti, 4159408

INTEGRATIVE MULTIDIMENSIONAL ANALYSIS OF IMMUNE SIGNATURES USING MULTI-OMICS DATA FOR PATIENT STRATIFICATION: A CASE STUDY ON MYELODYSPLASTIC SYNDROMES (MDS)

EHA Library, Ziying Zhang, 4159407

BARICITINIB CORRECTS AP2-NAK MEDIATED C-MPL ENDOCYTIC DYSREGULATION TO RESTORE MEGAKARYOCYTES TPO-RA SENSITIVITY IN IMMUNE THROMBOCYTOPENIA

EHA Library, Zhuo-Yu An, 4159390

A PHASE 2 STUDY OF IANALUMAB IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH AT LEAST TWO LINES OF THERAPY (VAYHIT3)

EHA Library, Charlotte Bradbury, 4159389

ATRIAL FIBRILLATION PREVALENCE AND ITS MANAGEMENT IN THE AGING TRANSFUSION-DEPENDENT BETA-THALASSEMIA

EHA Library, Valeria Di Stefano, 4159370

TREATMENT OF PATIENTS WITH SEVERE TRANSFUSION-DEPENDENT ß-THALASSEMIA WITH CS-101, AN AUTOLOGOUS, EX VIVO EDITED, CD34+ HEMATOPOIETIC STEM CELL PRODUCT USING INNOVATIVE TRANSFORMER BASE EDITOR (TBE)

EHA Library, Jia Chen, 4159368

CAR-T CELLS SPECIFIC TOXICITIES AS MAJOR DETERMINANTS OF NON-RELAPSE MORTALITY: AN ANALYSIS FROM THE ITALIAN CART-SIE STUDY

EHA Library, Angelica Barone, 4159359

ENHANCED CAR T-CELL EXPANSION AND DURABLE COMPLETE RESPONSES WITH NKTR-255 PLUS LISOCABTAGENE MARALEUCEL IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Alexandre Hirayama, 4159357

DURABLE EFFICACY WITH FIXED-DURATION EPCORITAMAB + POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA-R-CHP) FOR 1L DIFFUSE LARGE B-CELL LYMPHOMA (EPCORE NHL-5)

EHA Library, Daniel Kerr, 4159324

A PIVOTAL STUDY OF SHR2554, AN ORAL INHIBITOR AGAINST ENHANCER OF ZESTE HOMOLOG 2 (EZH2), IN RELAPSED OR REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL)

EHA Library, Yuqin Song, 4159323

FIRST DISCLOSURE OF EPCORITAMAB + R-ICE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): EPCORE NHL-2

EHA Library, Raul Cordoba, 4159322

MUTATIONS IN SETBP1 DRIVE GRANULOCYTE LINEAGE OUTPUT AND LEUKEMOGENESIS VIA KAT7-MEDIATED EPIGENETIC MODULATION AND TRANSCRIPTIONAL REPROGRAMMING

EHA Library, Samantha Tauchmann, 4159290

DISCOVERY OF FIRST-IN-CLASS PRECISION ANTIBODY DRUG CONJUGATES TARGETING MUTANT CALRETICULIN FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS.

EHA Library, Norman Fultang, 4159288

ROBUST MOUSE MODEL OF SECONDARY ACUTE MYELOID LEUKEMIA: REVEALING KEY ROLE OF TP53 MUTATIONS AND PERSISTENT STAT5 ACTIVATION.

EHA Library, Stefan N. Constantinescu, 4159287

LONG-TERM FOLLOW-UP OF PREDOMINANTLY ASIAN PATIENTS WITH RELAPSED/REFRACTORY FLT3-MUTATED ACUTE MYELOID LEUKEMIA TREATED WITH GILTERITINIB VERSUS SALVAGE CHEMOTHERAPY IN THE PHASE 3 COMMODORE TRIAL

EHA Library, Jianxiang Wang, 4159220

THE COMBINATION OF A FLT3-ITD, NPM1MUT AND AN EPIGENETIC REGULATORY GENE MUTATION CONFERS UNIQUE SENSITIVITY TO QUIZARTINIB: ANALYSIS FROM THE QUANTUM-FIRST TRIAL

EHA Library, Mark Levis, 4159217

HETEROGENEOUS TRANSCRIPTION FACTOR AND SUPER-ENHANCER DYSREGULATION IN AML REVEALED BY INTEGRATED CHROMATIN PROFILING

EHA Library, Yotaro Ochi, 4159210

INTRINSIC RNA RECEPTOR SIGNALING IN AML MODULATES 5'-AZACITIDINE EFFICACY AND CAN BE RE-SENSITIZED DURING ACQUIRED RESISTANCE BY ALL-TRANS RETINOIC ACID

EHA Library, Nadia El Khawanky, 4159209

SINGLE-CELL RNA AND ATAC-SEQ HIGHLIGHTS RAPID ADAPTATION OF MONOSOMY 7 PROGENITOR POPULATIONS TO NOVEL THERAPIES IN AML

EHA Library, Rachel Thijssen, 4159207

CAN CAR T-CELL THERAPY BE A DEFINITIVE TREATMENT FOR ADULT R/R B-ALL WITHOUT TRANSPLANT? LONG-TERM FINDINGS AND PREDICTORS OF SUSTAINED REMISSION FOR OBECABTAGENE AUTOLEUCEL

EHA Library, Jae H. Park, 4159190

OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN STRATIFIED BY CUMULATIVE DOSE

EHA Library, Wendy Stock, 4159188

EFFICACY AND SAFETY OUTCOMES OF OBECABTAGENE AUTOLEUCEL (OBE-CEL) STRATIFIED BY AGE IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL)

EHA Library, Bijal D. Shah, 4159191

MECOM IS A MASTER REPRESSOR OF MYELOID DIFFERENTIATION THROUGH DOSE CONTROL OF CEBPA IN ACUTE MYELOID LEUKEMIA

EHA Library, Dorien Pastoors, 4159208

DE NOVO DESIGN OF A CHROMATIN READER ZMYND8-TARGETING PEPTIDE PROTAC FOR ACUTE MYELOID LEUKEMIA THERAPY

EHA Library, hui feng, 4159211

EFFICACY AND SAFETY OF PIVEKIMAB SUNIRINE (PVEK) IN PATIENTS (PTS) WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN) IN THE CADENZA STUDY

EHA Library, Naveen Pemmaraju, 4159218

PHASE I/II STUDY OF DECITABINE, VENETOCLAX, AND QUIZARTINIB TRIPLET COMBINATION IN FLT3-ITD MUTATED AML

EHA Library, Musa Yilmaz, 4159219

A CD33-DELETED ALLOGRAFT (TREM-CEL) ENABLES GEMTUZUMAB OZOGAMICIN MAINTENANCE POST-HEMATOPOIETIC CELL TRANSPLANT WITH THERAPEUTIC EXPOSURES AND LOW TOXICITY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Guenther Koehne, 4159221

IMPACT OF VENETOCLAX-BASED THERAPIES ON AUTOIMMUNE CYTOPENIAS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: FINAL ANALYSIS OF A MULTICENTER STUDY CONDUCTED BY ERIC

EHA Library, Candida Vitale, 4159234

OVERALL SURVIVAL AND DURATION OF TRANSFUSION INDEPENDENCE FOR FIRST-LINE ESA-NAIVE PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES TREATED WITH LUSPATERCEPT VS EPOETIN ALFA IN THE COMMANDS TRIAL

EHA Library, Valeria Santini, 4159254

EFFICACY OF MACROPHAGE CHECKPOINT CLEVER-1 INHIBITION WITH BEXMARILIMAB PLUS AZACITIDINE IN MYELODYSPLASTIC SYNDROME: RESULTS FROM THE PH1/2 BEXMAB STUDY

EHA Library, Mika Kontro, 4159255

DURABLE RESPONSES TO LENZILUMAB - AZACITIDINE COMBINATION THERAPY IN HIGH RISK PROLIFERATIVE CMML WITH SUPPRESSION OF CBL AND RAS MUTANT SUBCLONES

EHA Library, Daniel Thomas, 4159256

ELRANATAMAB IN COMBINATION WITH DARATUMUMAB AND LENALIDOMIDE (EDR) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) NOT ELIGIBLE FOR TRANSPLANT: INITIAL RESULTS FROM MAGNETISMM-6 PART 1

EHA Library, Meletios Dimopoulos, 4159283

ANALYSIS OF SUSTAINED MRD NEGATIVITY IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE WITH OR WITHOUT ISATUXIMAB (PHASE III ISKIA TRIAL)

EHA Library, Francesca Gay, 4159285

ISATUXIMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (ISA-KRD) FOR HIGH-RISK (HR) NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): FIRST-TIME REPORT OF THE FULL COHORT OF TRANSPLANT-ELIGIBLE (TE) PATIENTS IN THE GMMG-CONCEPT TRIAL

EHA Library, Lisa Leypoldt, 4159286

PHASE 2 STUDY OF TALQUETAMAB + TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND EXTRAMEDULLARY DISEASE: REDIRECTT-1

EHA Library, Shaji Kumar, 4173809

INCA33989 IS A NOVEL, FIRST IN CLASS, MUTANT CALRETICULIN-SPECIFIC MONOCLONAL ANTIBODY THAT DEMONSTRATES SAFETY AND EFFICACY IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)

EHA Library, John Mascarenhas, 4173810

TRANSCRIPTIONAL REPROGRAMMING AND SURVIVAL CO-DEPENDENCIES OF CHRONIC LYMPHOCYTIC LEUKEMIA RESISTANT TO VENETOCLAX

EHA Library, Daisy Diaz Rohena, 4173811

SAFETY AND EFFICACY OF CM313 IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL

EHA Library, Yanmei Xu, 4173812

HCT FRAILTY SCALE (HCT-FS) FOR ASSESSING FRAILTY IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT PATIENTS. RESULTS FROM A MULTICENTER AND PROSPECTIVE CANADIAN AND SPANISH INITIATIVE

EHA Library, Maria Queralt Salas, 4173813

INVESTIGATION OF CHANGE IN IPSS-M AND MOLECULAR REMISSION STATUS AS PREDICTORS OF POST-TRANSPLANTATION OUTCOME - A NORDIC MULTICENTRE STUDY

EHA Library, Joel Wiggh, 4160696

GENOMIC AND CLINICOPATHOLOGIC DETERMINANTS OF OLIGOMONOCYTIC CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Guillermo Montalban-Bravo, 4160695

SAFETY AND EFFICACY OF AZACITIDINE SEQUENTIAL SELINEXOR IN NEWLY DIAGNOSED PATIENTS WITH MYELODYSPLASTIC SYNDROMES EB1 OR EB2: A SINGLE-CENTER, SINGLE-ARM, PHASE IB/II TRIAL

EHA Library, Liya Ma, 4160694

RISK STRATIFICATION IN HYPOMETHYLATING AGENT-TREATED PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A MULTIVARIATE MODEL (MDS-HOPE)

EHA Library, Kelly Chien, 4160693

LUSPATERCEPT MODULATES THE TRANSCRIPTIONAL PROGRAM OF HSPCS OF MDS PATIENTS AT THE SINGLE CELL LEVEL.

EHA Library, Ioannis Kotsianidis, 4160690

PATHOPHYSIOLOGICAL ABNORMALITIES OF RED BLOOD CELLS IN MYELODYSPLASTIC SYNDROMES AS POTENTIAL DIAGNOSTIC AND THERAPEUTIC MARKERS

EHA Library, Pinelopi Vryttia, 4160689

UTILITY OF SNP-ARRAY FOR DETECTING NUMERICAL ALTERATIONS AND LOSS OF HETEROZYGOSITY IN SMD AND CMML PATIENTS WITH NORMAL KARYOTYPE

EHA Library, Carmen Loredo Alvarez, 4160688

ARSENIC SULFIDE NANOCRYSTAL FORMULATION INCREASES EFFECTIVE ERYTHROPOIESIS OF MDS THROUGH SCAVENGING REACTIVE OXIDATIVE SPECIES AND STRESS GRANULES FORMATION

EHA Library, Tao Wang, 4160687

CCR2-DIRECTED TARGETING OF MONOCYTIC-BIASED PROGENITOR AND MONOCYTIC POPULATIONS IN CHRONIC MYELOMONOCYTIC LEUKEMIA AND ACUTE MONOCYTIC LEUKEMIA

EHA Library, Guillermo Montalban-Bravo, 4160686

IMPACT OF LUSPATERCEPT VS EPOETIN ALFA TREATMENT (TX) ON GENOMIC LANDSCAPE AND MUTATIONAL BURDEN IN PATIENTS (PTS) WITH LOWER-RISK (LR) MYELODYSPLASTIC SYNDROMES (MDS) IN THE COMMANDS TRIAL

EHA Library, Rami S. Komrokji, 4160685

RESIDUAL DISEASE AND RELAPSE: HOW STOCHASTIC FOUNDER EFFECTS SHAPE PEDIATRIC ALL OUTCOMES

EHA Library, Virginia Turati, 4160407

MAPPING THE AKR1C3 CIS-REGULOME IN ACUTE LYMPHOBLASTIC LEUKEMIA TO ENHANCE TARGETED THERAPY WITH A NEW AKR1C3-ACTIVATED PRODRUG

EHA Library, Hansen Kosasih, 4160408

EPIGENETIC DETERMINANTS CONFERRING GLUCOCORTICOID RESISTANCE IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Yashna Walia, 4160410

DIGITAL DROPLET PCR FOR MINIMAL RESIDUAL DISEASE MONITORING IN PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT FROM THE PROSPECTIVE NORTHERN ITALY LEUKEMIA GROUP (NILG) ALL 10/07 STUDY

EHA Library, Francesco Ballardini, 4160411

ADAR1-MEDIATED RNA EDITING IN RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)

EHA Library, Ioannis Kotsianidis, 4160680

SINGLE-CELL TRANSCRIPTOMICS REVEALS BONE MARROW CHANGES IN MDS PATIENTS RESPONDING TO BEXMARILIMAB AND AZACYTIDINE

EHA Library, Jesper Mickos, 4160682

PROGENITOR IMBALANCE AND TRANSCRIPTIONAL DYSREGULATION AS POTENTIAL DRIVERS OF ABERRANT HEMATOPOIESIS IN MDS

EHA Library, Carmen Rodriguez-Res, 4160683

TRANSCRIPTIONAL REMODELING OF THE NON-IMMUNE BONE MARROW MICROENVIRONMENT IN MDS PATIENTS WITH SF3B1 MUTATIONS: INSIGHTS INTO BIOLOGY AND THERAPEUTIC IMPLICATIONS

EHA Library, Isabel A. Calvo, 4160684

ANALYSIS OF PREANALYTICAL VARIABILITY ON PLASMA MIRNA EXPRESSION PROFILE BY NEXT GENERATION SEQUENCING TO REVEAL SPECIFIC POTENTIAL DIAGNOSTIC BIOMARKERS OF MYELODYSPLASTIC SYNDROME.

EHA Library, Alessandra Giannella, 4160691

ROLE OF BYSTANDER CD8 T CELLS PRODUCING GRANZYME K IN MDS PROGRESSION

EHA Library, Yannick Simoni, 4160692

CLONAL HIERARCHY AND ALLELIC BURDEN ANALYSIS OF TET2 MUTATIONS IN MYELODYSPLASTIC NEOPLASMS

EHA Library, Yudi Zhang, 4160698

THE ROLE OF THE ADENOSINERGIC PATHWAY IN THE RESPONSE TO AZACYTIDINE IN HR-MDS PATIENTS

EHA Library, Ioannis Kotsianidis, 4160700

USING PSM COMPARING THE PROGNOSTIC DIFFERENCES BETWEEN FIRST-LINE AUTOLOGOUS TRANSPLANTATION AND CHEMOTHEROPY ALONE IN NEWLY DIAGNOSED DLBCL PATIENTS WITH IPI ≥3

EHA Library, Hongmei Jing, 4161151

OUTCOMES OF IMETELSTAT THERAPY IN PATIENTS WITH RING SIDEROBLAST-NEGATIVE LOWER-RISK MYELODYSPLASTIC SYNDROMES FROM THE POOLED IMERGE STUDY POPULATIONS

EHA Library, Valeria Santini, 4160697

MEASURABLE RESIDUAL DISEASE IN CD34+ CELLS IN MYELODYSPLASTIC SYNDROME AFTER ALLOGENIC STEM CELL TRANSPLANTATION

EHA Library, Carolin Lindholm, 4160699

TRANSCRIPTIONAL ALTERATIONS IN THE BONE MARROW CELLS OF MYELODYSPLASTIC SYNDROME PATIENTS WITH MUTATIONS IN THE COHESIN SUBUNIT STAG2 ARE INDICATIVE OF REDUCED SENSITIVITY OF HEMATOPOIETIC STEM CELLS TO EXTRINSIC SIGNALS AND REDUCED IMMUNOGENIC POTENTIAL OF THEIR PROGENY

EHA Library, Marcus Buschbeck, 4160681

AGE-DEPENDENT TUMOUR-IMMUNE INTERACTIONS GOVERNS IMMUNOTHERAPY RESPONSES IN LEUKAEMIA AND OTHER PAEDIATRIC CANCERS

EHA Library, Sebastien Malinge, 4160409